Pfizer's Corona vaccine has so far received emergency approval in more than 5 countries, including the United States, Britain. The process of vaccinating health workers and high-groups has also started in many countries. But emergency approval will not be easy for him in India. The Subject Expert Committee of the Drug Regulator recommending emergency approval may ask him for trials in India.
According to a Mint report, the trial data that Pfizer has presented, it is not enough to have trial data related to Volunteers associated with Indian Ethnicity. A researcher associated with the regulatory process of the vaccine said that for any vaccine, you have to provide data on trials on the local population. If Pfizer's Global Trials had some data on the trials on the Indian population, it could have been exempted from the imperative of clinical trials. But it seems that his data is not enough. The possibility of waiver of clinical trials seems quite low at this time.
Earlier, Dr. Gagandeep Kang, the country's top vaccine scientist and professor of Christian Medical College, had also expressed the possibility that India's drug regulator could ask foreign vaccine for trials in India if they applied for emergency approval. May be asked to do this trial on 100 Indians. All this is decided on the data of trials conducted worldwide.
What is the need for local trials?
If the Drug Controller General of India VG Somani and the Subject Expert Committee approved the Pfizer vaccine, it would be a completely new technology here. Pfizer's vaccine is made up of messenger-RNA or mRNA technology, trials of which have not happened in India. In such a situation, giving emergency approval based on only global trial data can be risky.
Pfizer's global phase-3 clinical trial was attended by 37,000 volunteers. Of this only 4.3% of people were of Asian descent. Even though the overall efficacy of the vaccine was 95%, its success rate was 74.4% for people of Asian descent. 50% is considered as a cut-off for the corona vaccine, so 74.4% can also be considered a good figure. But it is also clear that the sample size was not enough.
Didn't the foreign vaccine approve before this?
A vaccinologist associated with the government organization says that it would be unprecedented to give Pfizer emergency approval locally without clinical trials. Until now, local clinical trials were mandatory for all vaccines made or imported in India. A big reason for this is India's diversified demography and socio-economic diversity. This has a great impact on the safety and effectiveness of the vaccine.
India Healthcare Analyst Nitya Balakrishnan of Sanford Brentstein said in a report that the sample size is not enough. We can understand the compulsion to consider giving exemption of clinical trials, but health volunteers have to take a careful decision before dosing. There is also not enough basis to grant trial exemption.
What about the rest of the vaccine?
Currently, along with Pfizer, Serum Institute of India (SII) and Bharat Biotech have also applied for emergency approval for their vaccines. SII has sought approval for the Covyshield vaccine developed by Oxford and AstraZeneca, with phase-3 trials currently running across the country. Similarly, phase-3 trials of the first indigenous corona vaccine-covaxin of Bharat Biotech are also being run in many hospitals in the country.
Pfizer vaccine will be cheaper for Indians
Pfizer has said that its vaccine BNT162b2 will be priced in such a way that people have to spend little or no. In this, he is also willing to work with the Government of India. In the US, the company has fixed the price of one dose of its vaccine at $ 19.5 (Rs 1,440). But in India, this rate may be reduced.
Another problem with Pfizer's vaccine is to keep it at -70 ° C, for which the company has developed special temperature-controlled thermal shippers, which can be used as a temporary storage unit. Compared to Pfizer, SII's vaccine - Covyshield is going to be around 3 dollars i.e. about 221 rupees. Similarly, the Russian vaccine Sputnik V will also be cheaper than Pfizer and one of its doses will cost 10 dollars (Rs 735). The vaccines of indigenous vaccine companies Bharat Biotech and Zydus Cadila are priced between $ 3- $ 6, ie between 220 to 500 rupees.
Har Ghar Tiranga: Upload a selfie with tricolor here, PM Modi urged, know-how
The country is going to celebrate its 77th Independence Day on the 15th of August. All preparations have been made for the hoisting of the national flag and the program at the Red Fort in the capital
Jammu and Kashmir News: The two terrorists were planning an attack like Pulwama, now the search for 40 kg explosives is on
Terrorists Killed In J&K: There has been a big disclosure about two terrorists killed in Kashmir on Wednesday. The disclosure is that both of them wanted to carry out a big attack on the lines of
Vijay Hazare Trophy: Bengal's 'trio' proved to be a super hit, Jammu and Kashmir bowled out for their lowest score.
The Bengal trio of Mukesh Kumar (4/16), Akash Deep (4/32), and Mohammed Shami (2/14) bowled out Jammu and Kashmir for just 63 runs in a Vijay Hazare Trophy match on Wednesday.
After the increasing cases of the corona, the center asked the two states of Kerala and Maharashtra to consider night curfew
The central government has asked two states of the country - Kerala, and Maharashtra to consider imposing a night curfew. For the last two days, more than 40 thousand new cases of corona are being
74 lakh crores hidden in Afghanistan. Treasure: Estimated to be rich in lithium, this can fulfill India's electric vehicle dream, gold and cobalt also reserves
Afghanistan is one of the poorest countries in the world, but Afghanistan has mineral reserves of more than one trillion dollars i.e. 74.37 lakh crore rupees. In 2010, US military officials and the
Coronavirus Update: 159 new cases of corona found in the country in 24 hours, decrease in active cases, know the latest updates
There is a continuous decrease in the cases of the corona virus in India. In the last 24 hours, 159 new cases of Covid-19 have been reported in India. A day earlier on Sunday, 173 new cases of corona
What is Bali's connection with NEET Paper Leak? CBI is busy investigating the horoscope of Oasis Principal, coaching teacher is also on the radar
Oasis School in Hazaribagh district of Jharkhand remains the center of CBI's investigation in the NEET question paper leak case. Now a teacher at a coaching institute here is also under investigation.
Weather Update Today: Chance of rain in Delhi-UP and a hailstorm in Punjab, snowfall alert in the valley today
There is currently relief from the cold in many states of North India. The Meteorological Department has expressed the possibility of rain in North India including the national capital Delhi.
More than 33 lakh people have been vaccinated in the country so far, Uttar Pradesh-Karnataka the highest vaccination
Today is the 15th day of the ongoing vaccination program against Corona. Under this, the first dose of vaccine has been given to more than 33 lakh people in the country so far. According to the Health
Rajkummar Rao: Rajkummar Rao expressed happiness over the success of 'Stree 2', and said- these numbers are beyond our expectations
Rajkummar Rao is very excited about the success of his recent horror-comedy film 'Stree 2'. It stars Shraddha Kapoor, Pankaj Tripathi, Abhishek Banerjee, and Aparshakti Khurana in the lead roles along
